ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NPTH Enpath Medical (MM)

0.00
0.00 (0.00%)
After Hours
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Enpath Medical (MM) NASDAQ:NPTH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Enpath Medical Announces First Quarter 2007 Earnings Release and Conference Call Date

20/04/2007 2:00pm

PR Newswire (US)


Enpath (NASDAQ:NPTH)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Enpath Charts.
MINNEAPOLIS, April 20 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH) announced today that it will release its first quarter 2007 financial results at the close of market on Wednesday, May 2, 2007. The management team of Enpath Medical will host a conference call to discuss the results beginning at 3:30 P.M. Central Time, also on Wednesday, May 2, 2007. To participate, please call 800-240-6709 for domestic callers and 303-205-0055 for international callers. A recording of the conference call will be available approximately one hour after the conclusion of the call and will be accessible for seven days. To access the replay, please dial 800-405-2236 for domestic callers and 303-590-3000 for international callers; please reference the passcode 11088660#. The conference call will also be webcast live on the company's web site, http://www.enpathmed.com/, and may be accessed by clicking on the 1st Quarter 2007 Earnings Call icon. An audio replay will be archived on the Enpath website for one year. About Enpath Medical Enpath Medical, Inc., headquartered in Plymouth, Minnesota, is a leader in the design, development, manufacture and marketing of percutaneous delivery systems and stimulation leads technologies. Its proprietary products include venous vessel introducers, articulating and fixed curve delivery catheters, epicardial and endocardial stimulation leads, and other products for use in pacemaker, defibrillator, catheter and infusion port procedures as well as neuromodulation markets. Its products, which are primarily finished goods, are sold worldwide through partnering relationships with other medical device companies. DATASOURCE: Enpath Medical, Inc. CONTACT: Scott Youngstrom of Enpath Medical, Inc., +1-763-951-8211; or investors, Doug Sherk or Jennifer Beugelmans, +1-646-201-5447, or media, Steve DiMattia, +1-646-201-5445, all of EVC Group, for Enpath Medical, Inc. Web site: http://www.enpathmed.com/

Copyright

1 Year Enpath Chart

1 Year Enpath Chart

1 Month Enpath Chart

1 Month Enpath Chart

Your Recent History

Delayed Upgrade Clock